Smith S K, Brown V A, Dewar A E, Stockdill G, Cohen B, Maddy A H
Clin Exp Immunol. 1985 Jan;59(1):55-63.
The surface glycoproteins of lymphocytes isolated from patients suffering from B cell chronic lymphocytic leukaemia (B-CLL) have been studied by radioactive labelling with impermeable probes and with MoAb. Several features not found in normal B cells have been observed. The abnormalities found in the expression of polypeptides of the leucocyte common (L-C) antigen, identified by appropriate MoAb, have been examined in detail. It has been shown by both biochemical analysis and MoAb binding that this group of polypeptides can, within a panel of B-CLL patients, range from a typical B cell pattern to the pattern resembling that normally found in T cells. The T lymphocyte profile is correlated with a poor prognosis (MVA C rating) and in the one patient where a change in the glycoprotein profile towards that of the T cell was observed, the change coincided with a clinical deterioration. The biological significance of the molecular diversity is discussed.
通过使用非渗透性探针和单克隆抗体进行放射性标记,对从患有B细胞慢性淋巴细胞白血病(B-CLL)的患者中分离出的淋巴细胞表面糖蛋白进行了研究。观察到了一些正常B细胞中未发现的特征。已详细检查了通过适当的单克隆抗体鉴定的白细胞共同(L-C)抗原多肽表达中的异常情况。生化分析和单克隆抗体结合均表明,在一组B-CLL患者中,这组多肽的范围可以从典型的B细胞模式到类似于正常T细胞中发现的模式。T淋巴细胞谱与预后不良(MVA C分级)相关,在一名观察到糖蛋白谱向T细胞谱变化的患者中,这种变化与临床病情恶化同时发生。讨论了分子多样性的生物学意义。